Description
An aglycone form of avermectin B1a; hyperpolarizes P. crassipes muscle fibers (MAC = 0.1 μM); decreases survival of C. elegans (MAC = 0.1 μM); prevents PTZ-induced seizures in mice (ED50 = 43.9 mg/kg)
Formal name: (6R,13S,25R)-22,23-didehydro-5-O-demethyl-28-deoxy-6,28-epoxy-13-hydroxy-25-[(1S)-1-methylpropyl]-milbemycin B
Synonyms:
Molecular weight: 584.7
CAS: 71828-14-3
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Antiparasitics|Anthelmintics||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Parasitic Diseases||Research Area|Neuroscience|Seizure Disorders